Dentsply Sirona/$XRAY

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Dentsply Sirona

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).

Ticker

$XRAY
Sector
Primary listing

Employees

14,000

Dentsply Sirona Metrics

BasicAdvanced
$2.7B
-
-$4.76
0.96
$0.64
4.73%

What the Analysts think about Dentsply Sirona

Analyst ratings (Buy, Hold, Sell) for Dentsply Sirona stock.

Bulls say / Bears say

Adjusted EBITDA rose 14.6% year-over-year to $197 million in Q2 2025, lifting the adjusted EBITDA margin to 21.1% from 17.5%, and underscoring improved operational efficiency (Dentsply Sirona).
Adjusted EPS increased 6.6% year-on-year to $0.52 in Q2 2025, surpassing the prior year’s $0.49 and demonstrating resilience in profitability despite top-line pressures (Dentsply Sirona).
The Essential Dental Solutions segment delivered 2.9% reported net sales growth in Q2 2025, showing strength in consumables amid broader volume headwinds (Dentsply Sirona).
Net sales fell 4.9% year-on-year (6.7% in constant currency) to $936 million in Q2 2025, reflecting soft end-market demand across its product portfolio (Dentsply Sirona).
U.S. net sales plunged 18.3% in Q2 2025 versus the prior year, highlighting a marked underperformance in its largest market (Dentsply Sirona).
The company recorded a $214 million non-cash impairment charge for goodwill and indefinite-lived intangibles in Q2 2025, resulting in a GAAP net loss of $45 million and undermining shareholder equity (Dentsply Sirona).
Data summarised monthly by Lightyear AI. Last updated on 4 Sept 2025.

Dentsply Sirona Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Dentsply Sirona Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $XRAY

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Sept26
Dentsply Sirona
DividendEx-dividend
Oct10
Dentsply Sirona
DividendPayment
$0.16Per share
FAQs